{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:24:28Z","timestamp":1763036668377},"reference-count":82,"publisher":"Akademiai Kiado Zrt.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Microbiology and Immunology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1556\/eujmi.1.2011.4.2","type":"journal-article","created":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T06:20:00Z","timestamp":1325658000000},"page":"267-278","source":"Crossref","is-referenced-by-count":22,"title":["The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders \u2014 Similarities and differences"],"prefix":"10.1556","volume":"1","author":[{"given":"G.","family":"F\u00fcst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08916930802024772","article-title":"Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases","volume":"41","author":"Niller H.H.","year":"2008","journal-title":"Autoimmunity"},{"key":"2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(63)90624-X","article-title":"Multiple sclerosis and poliomyelitis","volume":"2","author":"Poskanzer D.C.","year":"1963","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update","volume":"160","author":"Okada H.","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.29.1.60","article-title":"Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation","volume":"29","author":"Leibowitz U.","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio A.","year":"2007","journal-title":"Ann Neurol"},{"key":"6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)00033-X","article-title":"Migrant studies in multiple sclerosis","volume":"47","author":"Gale C.R.","year":"1995","journal-title":"Prog Neurobiol"},{"key":"7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/jnnp.56.5.454","article-title":"Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa","volume":"56","author":"Elian M.","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8","first-page":"175","article-title":"Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis","volume":"2","author":"Fraser K.B.","year":"1979","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410170412","article-title":"Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis","volume":"17","author":"Sumaya C.V.","year":"1985","journal-title":"Ann Neurol"},{"key":"10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: ameta-analysis","volume":"59","author":"Thacker E.L.","year":"2006","journal-title":"Ann Neurol"},{"key":"11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2249.2010.04121.x","article-title":"99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence","volume":"160","author":"Ascherio A.","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel A.E.","year":"2010","journal-title":"PLoS One"},{"key":"13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-Barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio A.","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1827.2006.01936.x","article-title":"Prevalence of Epstein-Barr virus in Japan: trends and future prediction","volume":"56","author":"Takeuchi K.","year":"2006","journal-title":"Pathol Int"},{"key":"15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","article-title":"Epstein-Barr virus in pediatric multiple sclerosis","volume":"291","author":"Alotaibi S.","year":"2004","journal-title":"JAMA"},{"key":"16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein-Barr virus in children with multiple sclerosis","volume":"67","author":"Pohl D.","year":"2006","journal-title":"Neurology"},{"key":"17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"Banwell B.","year":"2007","journal-title":"Lancet Neurol"},{"key":"18","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio A.","year":"2001","journal-title":"JAMA"},{"key":"19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom P.","year":"2004","journal-title":"Neurology"},{"key":"20","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin L.I.","year":"2005","journal-title":"JAMA"},{"key":"21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","article-title":"Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up","volume":"63","author":"DeLorenze G.N.","year":"2006","journal-title":"Arch Neurol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis","volume":"70","author":"Jager P.L.","year":"2008","journal-title":"Neurology"},{"key":"23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.08.004","article-title":"Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis","volume":"215","author":"Sundstrom P.","year":"2009","journal-title":"J Neuroimmunol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0b013e3181dad57e","article-title":"Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk","volume":"74","author":"Simon K.C.","year":"2010","journal-title":"Neurology"},{"key":"25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","article-title":"Primary infection with the Epstein-Barr virus and risk of multiple sclerosis","volume":"67","author":"Levin L.I.","year":"2010","journal-title":"Ann Neurol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger K.","year":"2011","journal-title":"Mult Scler"},{"key":"27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2010.06.007","article-title":"No evidence for intrathecal IgG synthesis to Epstein-Barr virus nuclear antigen-1 in multiple sclerosis","volume":"49","author":"Jafari N.","year":"2010","journal-title":"J Clin Virol"},{"key":"28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell R.A.","year":"2009","journal-title":"Neurology"},{"key":"29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"L\u00fcnemann J.D.","year":"2010","journal-title":"Ann Neurol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-1331.2010.03159.x","article-title":"Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity","volume":"17","author":"Ingram G.","year":"2010","journal-title":"Eur J Neurol"},{"key":"31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0404.2010.01410.x","article-title":"EBNA1 and LMP1 variants in multiple sclerosis cases and controls","volume":"124","author":"Simon K.C.","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2009.01.017","article-title":"Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection","volume":"8","author":"Pender M.P.","year":"2009","journal-title":"Autoimmun Rev"},{"key":"33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.0b013e3181dabfb5","article-title":"EBV and brain matter(s)?","volume":"74","author":"Ascherio A.","year":"2010","journal-title":"Neurology"},{"key":"34","unstructured":"Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, Smirnov IV et al.: Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J August 22, 2011 fj. 11-190769."},{"key":"35","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini B.","year":"2007","journal-title":"J Exp Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14737175.8.3.331","article-title":"Epstein-Barr virus in the development of multiple sclerosis","volume":"8","author":"Ascherio A.","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"37","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis S.N.","year":"2009","journal-title":"Brain"},{"key":"38","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis","volume":"132","author":"Peferoen L.A.","year":"2009","journal-title":"Brain"},{"key":"39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"Sargsyan S.A.","year":"2010","journal-title":"Neurology"},{"key":"40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The Essential Role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender M.P.","year":"2011","journal-title":"Neuroscientist"},{"key":"41","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1093\/brain\/awr197","article-title":"Epstein-Barr virus in the multiple sclerosis brain: a controversial issue report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria","volume":"134","author":"Lassmann H.","year":"2011","journal-title":"Brain"},{"key":"42","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awl067","article-title":"Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis","volume":"129","author":"Lunemann J.D.","year":"2006","journal-title":"Brain"},{"key":"43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","article-title":"EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis","volume":"162","author":"Sechel A.C.","year":"1999","journal-title":"J Immunol"},{"key":"44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","article-title":"Epstein-Barr virus infection of human brain microvessel endothelial cells: Anovel role in multiple sclerosis","volume":"230","author":"Casiraghi C.","year":"2011","journal-title":"J Neuroimmunol"},{"key":"45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender M.P.","year":"2003","journal-title":"Trends Immunol"},{"key":"46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-11-95","article-title":"Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes","volume":"11","author":"Pender M.P.","year":"2011","journal-title":"BMC Neurol"},{"key":"47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0961203306070009","article-title":"The curiously suspicious: a role for Epstein-Barr virus in lupus","volume":"15","author":"Harley J.B.","year":"2006","journal-title":"Lupus"},{"key":"48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.bor.0000240355.37927.94","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"18","author":"James J.A.","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"49","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","article-title":"Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure","volume":"44","author":"James J.A.","year":"2001","journal-title":"Arthritis Rheum"},{"key":"50","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James J.A.","year":"1997","journal-title":"J Clin Invest"},{"key":"51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jmv.10385","article-title":"Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1","volume":"70","author":"McClain M.T.","year":"2003","journal-title":"J Med Virol"},{"key":"52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot E.","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Esen BA, Yilmaz G, Uzun S, Ozdamar M, Aksozek A, Kamali S, Turkoglu S et al.: Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int July 26, 2010","DOI":"10.1007\/s00296-010-1573-4"},{"key":"54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1749-6632.2009.04754.x","article-title":"Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease","volume":"1173","author":"Zandman-Goddard G.","year":"2009","journal-title":"Ann NYAcad Sci"},{"key":"55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/art.21682","article-title":"An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus","volume":"54","author":"McClain M.T.","year":"2006","journal-title":"Arthritis Rheum"},{"key":"56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2008.12.008","article-title":"Aberrant Epstein-Barr viral infection in systemic lupus erythematosus","volume":"8","author":"Poole B.D.","year":"2009","journal-title":"Autoimmun Rev"},{"key":"57","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle M.R.","year":"2003","journal-title":"N Engl J Med"},{"key":"58","first-page":"45","article-title":"Epstein-Barr virus infection induces lupus autoimmunity","volume":"64","author":"Harley J.B.","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain M.T.","year":"2005","journal-title":"Nat Med"},{"key":"60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaut.2008.08.007","article-title":"Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments","volume":"31","author":"Poole B.D.","year":"2008","journal-title":"J Autoimmun"},{"key":"61","doi-asserted-by":"crossref","first-page":"e14488","DOI":"10.1371\/journal.pone.0014488","article-title":"Antibodies elicited in response to EBNA-1 may cross-react with dsDNA","volume":"6","author":"Yadav P.","year":"2011","journal-title":"PLoS One"},{"key":"62","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"Moon U.Y.","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"63","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang I.","year":"2004","journal-title":"J Immunol"},{"key":"64","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","article-title":"EBV and systemic lupus erythematosus: a new perspective","volume":"174","author":"Gross A.J.","year":"2005","journal-title":"J Immunol"},{"key":"65","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.4049\/jimmunol.0904065","article-title":"Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice","volume":"185","author":"Peters A.L.","year":"2010","journal-title":"J Immunol"},{"key":"66","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/rheumatology\/keq148","article-title":"Epstein-Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus","volume":"49","author":"Ulff-Moller C.J.","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1352458508097920","article-title":"Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis","volume":"15","author":"Lindsey J.W.","year":"2009","journal-title":"Mult Scler"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I et al.: Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun July 21, 2011","DOI":"10.1038\/gene.2011.42"},{"key":"69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI110083","article-title":"Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis","volume":"67","author":"Ferrell P.B.","year":"1981","journal-title":"J Clin Invest"},{"key":"70","first-page":"239","article-title":"Expansion of peripheral CD8+ CD28-T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis","volume":"32","author":"Klatt T.","year":"2005","journal-title":"J Rheumatol"},{"key":"71","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.184.5.1791","article-title":"T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis","volume":"184","author":"Scotet E.","year":"1996","journal-title":"J Exp Med"},{"key":"72","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","article-title":"Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction","volume":"48","author":"Balandraud N.","year":"2003","journal-title":"Arthritis Rheum"},{"key":"73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jbspin.2007.05.001","article-title":"Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update","volume":"74","author":"Toussirot E.","year":"2007","journal-title":"Joint Bone Spine"},{"key":"74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.21629","article-title":"Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"54","author":"Pratesi F.","year":"2006","journal-title":"Arthritis Rheum"},{"key":"75","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar2708","article-title":"Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies","volume":"11","author":"Miceli-Richard C.","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"76","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1874312900903010030","article-title":"Epstein-Barr virus (EBV) prevalence and the risk of reactivation in patients with inflammatory arthritis using anti-TNF agents and in thosewho are biologic naive","volume":"3","author":"McKeown E.","year":"2009","journal-title":"Open Rheumatol J"},{"key":"77","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/rheumatology\/keq159","article-title":"Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment","volume":"49","author":"Magnusson M.","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"78","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante P.","year":"2010","journal-title":"Ann Neurol"},{"key":"79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.22031","article-title":"Epstein-Barr virus: Trigger for autoimmunity?","volume":"67","author":"Kaminski H.J.","year":"2010","journal-title":"Ann Neurol"},{"key":"80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/978-1-4419-8216-2_7","article-title":"Epigenetic dysregulation of Epstein-Barr virus latency and development of autoimmune disease","volume":"711","author":"Niller H.H.","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"81","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen M.","year":"2007","journal-title":"Vaccine"},{"key":"82","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","article-title":"A phase I trial of Epstein-Barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation","volume":"88","author":"Rees L.","year":"2009","journal-title":"Transplantation"}],"container-title":["European Journal of Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/eujmi.1.2011.4.2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:14:54Z","timestamp":1713312894000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/eujmi.1.2011.4.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1556\/EuJMI.1.2011.4.2"],"URL":"https:\/\/doi.org\/10.1556\/eujmi.1.2011.4.2","relation":{},"ISSN":["2062-509X","2062-8633"],"issn-type":[{"value":"2062-509X","type":"print"},{"value":"2062-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}